" class="no-js "lang="en-US"> Jemincare - Medtech Alert
Monday, July 28, 2025
Jemincare | Pharmtech Focus

Jemincare

About Jemincare

Jemincare

Jiangxi Jemincare Group Co., Ltd. is a leading pharmaceutical company from China. Founded in 1999, Jemincare is mainly engaged in pharmaceutical industry. The company is dedicated to the development, manufacturing and commercialization of therapeutics in its strategic fields including oncology, nephrology, cerebro-cardiovascular, anti-infection, analgesic, respiratory and Pediatrics. Shanghai Jemincare Pharmaceutical Co., Ltd is the R&D center of Jiangxi Jemincare Group Co., Ltd. Shanghai Jemincare has developed a strong team with around 500 scientists comprised by 3 innovation centers, Small Molecule Innovative Center, Biologics Innovation Center and Technology Innovation Center. The androgen receptor degrader program was developed by the Small Molecule Innovation Center which had more than 10 programs entering IND or IND-enabling stage and 3 programs entering clinical stage.

Related Story

Jemincare Announces Exclusive License Agreement with Genentech to Develop and Commercialize Novel Oral Androgen Receptor Degrader

August 18 2022

Jemincare, a leading pharmaceutical company from China, announced today that it and its wholly owned subsidiary […]